NLS Column Business

In today’s rapidly shifting global landscape, it’s clear that the future of humanity hinges on how we invest in people, particularly leaders, right now. 

The EU legislation for substances of human origin (SoHOs) has been revised, bringing blood products, tissues and cells under one regulation.

It’s an exciting time to be a part of Norway’s health and life science environment, with a marked uptick in activity and a distinct sense of progress brewing.

Marketing specialist, Margery Rothenberg, shares her experiences and thoughts on culture clashes, linguistics, and Scandinavian delicacies. I just completed approximately a year and a half working remotely, from my home in New York, with a Swedish oncology diagnostics company. Technology enabled this dynamic and trust fueled success. I had worked in the past for multinationals, […]

Nordic life science companies are generally of good quality, but can often be better at pitching compared to US-based companies and entrepreneurs. Effective pitching is a skill, and is centered on good storytelling to get an investor’s full attention and buy-in. Since I work for the life science VC, HealthCap, I thought I would share […]

In this world of rapidly changing regulatory requirements and hyper-competitive global environment, life science companies need to pursue true digital transformation by leveraging comprehensive solutions to provide intelligence-driven insights at precisely the right moment within the organization’s workflows. Historically, quality operations supporting product lifecycle activities had a significant percentage of time dedicated to inspection, verification […]